Ozempic in Canada

Semaglutide, authorised for type 2 diabetes. Our provider comparison is in editorial testing — the generic hub covers the same molecule at a lower price.

Updated: July 28, 2026

Last reviewed: July 27, 2026 · Editorial team · Canadian availability verified per province

Editorial testing in progress

We have not finished verifying Canadian ozempic providers against real provincial availability, and we would rather publish nothing than publish rankings we have not checked. In the meantime, our published categories below are live.

Semaglutide Semaglutide for Weight Loss

Prescription notice

GLP-1 medications, finasteride, NAD+ injections and the other treatments compared on this site are prescription-only in Canada. A prescription is issued only when a clinician licensed in your province determines it is clinically appropriate for you. Approval is never guaranteed.

Explore More Treatments

Best Semaglutide in Canada

Semaglutide in Canada — generic, Ozempic and Wegovy — from licensed Canadian telehealth clinics, compared on all-in monthly cost.

Best Semaglutide for Weight Loss in Canada

Semaglutide weight loss programs from licensed Canadian telehealth clinics, compared on all-in monthly cost in CAD.

Ozempic Availability by Province

Telehealth is regulated provincially in Canada. Confirm your province is served before paying a consultation fee.

Ontario British Columbia Alberta Quebec Manitoba Saskatchewan Nova Scotia New Brunswick Prince Edward Island Newfoundland and Labrador

Frequently Asked Questions

Type 2 diabetes, at doses up to 2.0 mg weekly. Weight management is not its authorised indication in Canada — that is Wegovy, which is the same molecule titrated to 2.4 mg. Prescribing Ozempic for weight management alone is off-label, which is permitted but is a clinical judgement the prescriber makes and documents.

Substantially, in the Canadian programs we track — generic semaglutide starts around $149 a month against $250 to $400 for brand-name programs. Health Canada authorised the generic on demonstrated bioequivalence, so the active ingredient and strengths are the same.

References and further reading

Health Canada, Ozempic Summary Basis of Decision (Health Canada). Canadian approval of semaglutide for type 2 diabetes.
NEJM, SELECT cardiovascular outcomes trial (New England Journal of Medicine). Cardiovascular benefit in overweight and obesity.
Diabetes Canada, Pharmacologic Glycemic Management guidelines (Diabetes Canada). How GLP-1 medicines fit into Canadian diabetes care.

Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.

Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.